Luke Sergott Analyst PerformanceDirector at BarclaysLuke Sergott is a stock analyst at Barclays in the healthcare sector, covering 27 publicly traded companies. Over the past year, Luke Sergott has issued 147 stock ratings, including buy, hold, and sell recommendations. While full access to Luke Sergott's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Luke Sergott's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings196 Last 6 YearsBuy Recommendations58.25% 113 Buy RatingsCompanies Covered27 Unique Companies Ratings Distribution194RatingsDistribution of strong buy, buy, hold, and sell ratings by Luke Sergott.RatingPercentageCount Strong Buy0.0%0 ratings Buy58.2%113 ratings Hold31.4%61 ratings Sell10.3%20 ratingsOut of 194 total stock ratings issued by Luke Sergott at Barclays, the majority (58.2%) have been Buy recommendations, followed by 31.4% Hold and 10.3% Sell.Best & Worst CallsBest Call0000.0%TXGApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ICLRFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ55.6% of companies on NASDAQ15 companiesNYSE44.4% of companies on NYSE12 companiesLuke Sergott, an analyst at Barclays, currently covers 27 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare27 companies100.0%Luke Sergott of Barclays specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageLIFE SCIENCES TOOLS & SERVICES20 companies74.1%BIOTECHNOLOGY3 companies11.1%HEALTHCARE PROVIDERS & SERVICES2 companies7.4%HEALTHCARE EQUIPMENT & SUPPLIES1 company3.7%HEALTHCARE TECHNOLOGY1 company3.7% About Luke SergottExperienced healthcare analyst with a focus in public and private Life Sciences and Diagnostics companies. Follow on LinkedIn Luke Sergott's Ratings History at Barclays Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsILMNIllumina7/31/2026Boost Price Target$205.09$160.00Underweight$0.0000.00% ROIGHGuardant Health7/31/2026Boost Price Target$152.35$200.00Overweight$0.0000.00% ROIFTREFortrea7/30/2026Boost Price Target$20.40$22.00Equal Weight$0.0000.00% ROITMOThermo Fisher Scientific7/24/2026Boost Price Target$573.44$650.00Overweight$0.0000.00% ROIDGXQuest Diagnostics7/23/2026Boost Price Target$227.51$250.00Overweight$0.0000.00% ROIMEDPMedpace7/23/2026Set Price Target$605.82$600.00$0.0000.00% ROIICLRIcon6/25/2026Boost Price Target$158.17$175.00Equal Weight$0.0000.00% ROITWSTTwist Bioscience6/24/2026Boost Price Target$85.00$95.00Overweight$0.0000.00% ROISHCSotera Health6/24/2026Boost Price Target$15.84$19.00Overweight$0.0000.00% ROIILMNIllumina6/24/2026Boost Price Target$164.93$145.00Underweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. GHGuardant Health6/24/2026Boost Price Target$130.83$150.00Overweight$0.0000.00% ROIFTREFortrea6/24/2026Boost Price Target$16.47$18.00Equal Weight$0.0000.00% ROIBRKRBruker6/24/2026Boost Price Target$55.11$60.00Overweight$0.0000.00% ROIAVTRAvantor6/24/2026Boost Price Target$9.41$8.00Underweight$0.0000.00% ROITXG10x Genomics6/24/2026Boost Price Target$31.87$40.00Overweight$0.0000.00% ROIICLRIcon6/24/2026Boost Price Target$160.50$160.00Equal Weight$0.0000.00% ROIAAgilent Technologies6/24/2026Boost Price Target$131.48$150.00Overweight$0.0000.00% ROINTRANatera6/24/2026Lower Price Target$253.95$260.00Overweight$0.0000.00% ROIWSTWest Pharmaceutical Services6/9/2026Upgrade$319.98$400.00Overweight$0.0000.00% ROIICLRIcon5/29/2026Boost Price Target$133.78$150.00Equal Weight$0.0000.00% ROIAAgilent Technologies5/28/2026Boost Price Target$134.52$145.00Overweight$0.0000.00% ROICERTCertara5/12/2026Lower Price Target$5.02$6.50Equal Weight$0.0000.00% ROIPACBPacific Biosciences of California5/11/2026Boost Price Target$1.40$1.50Underweight$0.0000.00% ROIGHGuardant Health5/8/2026Boost Price Target$92.26$120.00Overweight$0.0000.00% ROICRLCharles River Laboratories International5/8/2026Boost Price Target$181.95$220.00Overweight$0.0000.00% ROIWATWaters5/7/2026Boost Price Target$349.91$425.00Overweight$0.0000.00% ROIBRKRBruker5/7/2026Boost Price Target$42.30$53.00Overweight$0.0000.00% ROIRVTYRevvity5/7/2026Boost Price Target$100.56$105.00Equal Weight$0.0000.00% ROIRGENRepligen5/6/2026Boost Price Target$125.61$160.00Overweight$0.0000.00% ROIFTREFortrea5/6/2026Boost Price Target$14.53$16.00Equal Weight$0.0000.00% ROITWSTTwist Bioscience5/4/2026Boost Price Target$56.19$65.00Overweight$0.0000.00% ROIILMNIllumina5/1/2026Boost Price Target$126.74$122.00Underweight$0.0000.00% ROIQGENQiagen4/29/2026Set Price Target$33.98$38.00Equal Weight$0.0000.00% ROIWSTWest Pharmaceutical Services4/27/2026Boost Price Target$305.31$310.00Equal Weight$0.0000.00% ROIMEDPMedpace4/24/2026Lower Price Target$393.42$450.00Equal Weight$0.0000.00% ROIDGXQuest Diagnostics4/22/2026Boost Price Target$202.23$230.00Overweight$0.0000.00% ROITWSTTwist Bioscience4/14/2026Boost Price Target$50.38$55.00Overweight$0.0000.00% ROISHCSotera Health4/14/2026Lower Price Target$15.70$18.00Overweight$0.0000.00% ROIRGENRepligen4/14/2026Lower Price Target$122.59$145.00Overweight$0.0000.00% ROIGHGuardant Health4/14/2026Lower Price Target$82.21$115.00Overweight$0.0000.00% ROIALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I. (Ad)Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.See Jeff Brown and Marc Chaikin's full analysis and next steps hereFTREFortrea4/14/2026Lower Price Target$9.38$11.00Equal Weight$0.0000.00% ROIDHRDanaher4/14/2026Lower Price Target$195.94$230.00Overweight$0.0000.00% ROICRLCharles River Laboratories International4/14/2026Boost Price Target$178.06$210.00Overweight$0.0000.00% ROIAVTRAvantor4/14/2026Lower Price Target$8.18$7.00Underweight$0.0000.00% ROITXG10x Genomics4/14/2026Boost Price Target$23.58$30.00Overweight$0.0000.00% ROIRVTYRevvity4/14/2026Reiterated Rating$92.54$95.00Equal Weight$0.0000.00% ROIQGENQiagen4/14/2026Set Price Target$41.94$44.00Equal Weight$0.0000.00% ROIWSTWest Pharmaceutical Services4/14/2026Boost Price Target$267.83$275.00Equal Weight$0.0000.00% ROIAAgilent Technologies4/14/2026Lower Price Target$120.40$140.00Overweight$0.0000.00% ROIBRKRBruker4/14/2026Lower Price Target$39.90$45.00Overweight$0.0000.00% ROIMTDMettler-Toledo International4/14/2026Lower Price Target$1,342.04$1,500.00Overweight$0.0000.00% ROIPACBPacific Biosciences of California4/14/2026Lower Price Target$1.56$1.00Underweight$0.0000.00% ROITMOThermo Fisher Scientific4/14/2026Lower Price Target$527.26$625.00Overweight$0.0000.00% ROIQGENQiagen4/14/2026Downgrade$41.75$44.00Equal Weight$0.0000.00% ROIRVTYRevvity4/14/2026Downgrade$93.59$95.00Equal Weight$0.0000.00% ROIICLRIcon3/9/2026Lower Price Target$105.12$120.00Equal Weight$0.0000.00% ROIPACBPacific Biosciences of California3/6/2026Reiterated Rating$1.52$1.50Underweight$0.0000.00% ROICERTCertara3/6/2026Reiterated Rating$7.15$8.00Equal Weight$0.0000.00% ROIAVTRAvantor3/6/2026Reiterated Rating$8.52$8.50Underweight$0.0000.00% ROIMEDPMedpace3/6/2026Upgrade$469.38$500.00Equal Weight$0.0000.00% ROIIQVIQVIA3/6/2026Upgrade$178.50$210.00Overweight$0.0000.00% ROICERTCertara2/27/2026Lower Price Target$6.84$8.00Equal Weight$0.0000.00% ROIFTREFortrea2/27/2026Lower Price Target$10.38$12.00Equal Weight$0.0000.00% ROIAAgilent Technologies2/26/2026Lower Price Target$118.68$150.00Overweight$0.0000.00% ROIRGENRepligen2/25/2026Lower Price Target$131.37$175.00Overweight$0.0000.00% ROIGHGuardant Health2/20/2026Reiterated Rating$106.38$130.00Overweight$0.0000.00% ROICRLCharles River Laboratories International2/19/2026Lower Price Target$158.28$200.00Overweight$0.0000.00% ROIWSTWest Pharmaceutical Services2/13/2026Lower Price Target$242.88$265.00Equal Weight$0.0000.00% ROIBRKRBruker2/13/2026Lower Price Target$37.51$50.00Overweight$0.0000.00% ROIAVTRAvantor2/12/2026Lower Price Target$9.66$9.00Equal Weight$0.0000.00% ROIMEDPMedpace2/11/2026Lower Price Target$433.97$500.00Underweight$0.0000.00% ROIWATWaters2/10/2026Initiated Coverage$327.52$400.00Overweight$0.0000.00% ROIWATWaters2/10/2026Initiated Coverage$329.65$400.00Overweight$0.0000.00% ROIQGENQiagen2/6/2026Set Price Target$51.17$58.00Overweight$0.0000.00% ROIIQVIQVIA2/6/2026Lower Price Target$180.62$210.00Equal Weight$0.0000.00% ROITWSTTwist Bioscience2/3/2026Boost Price Target$46.81$50.00Overweight$0.0000.00% ROIRVTYRevvity2/3/2026Boost Price Target$106.98$118.00Overweight$0.0000.00% ROITMOThermo Fisher Scientific1/30/2026Boost Price Target$593.16$650.00Overweight$0.0000.00% ROITWSTTwist Bioscience12/15/2025Boost Price Target$30.93$39.00Overweight$0.0000.00% ROIRVTYRevvity12/15/2025Boost Price Target$100.53$115.00Overweight$0.0000.00% ROIQGENQiagen12/15/2025Reiterated Rating$47.63$57.89Overweight$0.0000.00% ROIRGENRepligen12/15/2025Boost Price Target$157.39$200.00Overweight$0.0000.00% ROINTRANatera12/15/2025Boost Price Target$231.95$270.00Overweight$0.0000.00% ROIMEDPMedpace12/15/2025Boost Price Target$557.90$525.00Underweight$0.0000.00% ROIIQVIQVIA12/15/2025Set Price Target$222.12$230.00$0.0000.00% ROIILMNIllumina12/15/2025Boost Price Target$134.87$110.00Underweight$0.0000.00% ROIICLRIcon12/15/2025Boost Price Target$186.58$200.00Equal Weight$0.0000.00% ROIGHGuardant Health12/15/2025Boost Price Target$102.07$120.00Overweight$0.0000.00% ROICRLCharles River Laboratories International12/15/2025Boost Price Target$192.95$215.00Overweight$0.0000.00% ROICERTCertara12/15/2025Lower Price Target$8.58$13.00Overweight$0.0000.00% ROIOne signature away. Expected within months. (Ad)On May 21, 2026, a federal bank board unanimously approved a nearly $3 billion loan to build a gold mine on American soil. Congress had 25 days notice and raised no objections. The company's own filings cite substantial support and partnership from the Department of War. Alongside gold, the deposit holds a second metal China has banned from export to the U.S., the only domestic reserve of its kind. The company is roughly one fiftieth the size of Newmont.Get the name and ticker before the signature is finalizedBRKRBruker12/15/2025Boost Price Target$45.13$55.00Overweight$0.0000.00% ROITXG10x Genomics12/15/2025Boost Price Target$15.46$22.00Overweight$0.0000.00% ROIFTREFortrea12/15/2025Set Price Target$15.72$15.00Equal Weight$0.0000.00% ROIAAgilent Technologies12/15/2025Upgrade$139.56$165.00Overweight$0.0000.00% ROIPACBPacific Biosciences of California12/15/2025Boost Price Target$2.12$2.00Equal Weight$0.0000.00% ROIMTDMettler-Toledo International12/15/2025Lower Price Target$1,414.57$1,550.00Overweight$0.0000.00% ROIFTREFortrea12/15/2025Upgrade$16.06$15.00Equal Weight$0.0000.00% ROIAAgilent Technologies11/25/2025Boost Price Target$155.81$165.00Equal Weight$0.0000.00% ROIEXASExact Sciences11/20/2025Reiterated Rating$100.67$105.00Equal Weight$0.0000.00% ROIEXASExact Sciences11/20/2025Downgrade$100.90Hold$0.0000.00% ROITWSTTwist Bioscience11/17/2025Lower Price Target$26.12$37.00Overweight$0.0000.00% ROIMTDMettler-Toledo International11/10/2025Boost Price Target$1,441.07$1,600.00Overweight$0.0000.00% ROICERTCertara11/7/2025Lower Price Target$9.43$14.00Overweight$0.0000.00% ROITXG10x Genomics11/7/2025Boost Price Target$14.90$17.00Overweight$0.0000.00% ROINTRANatera11/7/2025Boost Price Target$190.84$230.00Overweight$0.0000.00% ROICRLCharles River Laboratories International11/6/2025Boost Price Target$168.97$210.00Overweight$0.0000.00% ROIFTREFortrea11/6/2025Boost Price Target$11.77$10.00Underweight$0.0000.00% ROISHCSotera Health11/5/2025Boost Price Target$16.43$20.00Overweight$0.0000.00% ROIEXASExact Sciences11/4/2025Boost Price Target$66.98$77.00Overweight$0.0000.00% ROIBRKRBruker11/4/2025Boost Price Target$38.71$45.00Overweight$0.0000.00% ROIILMNIllumina10/31/2025Boost Price Target$99.01$100.00Underweight$0.0000.00% ROIGHGuardant Health10/30/2025Boost Price Target$72.27$85.00Overweight$0.0000.00% ROIAVTRAvantor10/30/2025Reiterated Rating$11.57$12.00Equal Weight$0.0000.00% ROIRGENRepligen10/29/2025Boost Price Target$151.57$175.00Overweight$0.0000.00% ROIRVTYRevvity10/28/2025Boost Price Target$97.11$105.00Overweight$0.0000.00% ROIWSTWest Pharmaceutical Services10/27/2025Boost Price Target$295.11$325.00Equal Weight$0.0000.00% ROIMEDPMedpace10/24/2025Boost Price Target$598.85$485.00Underweight$0.0000.00% ROIICLRIcon10/24/2025Lower Price Target$175.78$185.00Equal Weight$0.0000.00% ROITMOThermo Fisher Scientific10/23/2025Boost Price Target$568.42$625.00Overweight$0.0000.00% ROIDHRDanaher10/22/2025Boost Price Target$221.13$250.00Overweight$0.0000.00% ROIWSTWest Pharmaceutical Services10/2/2025Boost Price Target$271.85$275.00Equal Weight$0.0000.00% ROITWSTTwist Bioscience10/2/2025Lower Price Target$29.26$40.00Overweight$0.0000.00% ROITMOThermo Fisher Scientific10/2/2025Boost Price Target$531.69$585.00Overweight$0.0000.00% ROISHCSotera Health10/2/2025Boost Price Target$16.19$19.00Overweight$0.0000.00% ROIRVTYRevvity10/2/2025Lower Price Target$91.76$100.00Overweight$0.0000.00% ROIRGENRepligen10/2/2025Boost Price Target$145.81$160.00Overweight$0.0000.00% ROIIQVIQVIA10/2/2025Boost Price Target$203.94$200.00Equal Weight$0.0000.00% ROIILMNIllumina10/2/2025Boost Price Target$102.26$95.00Underweight$0.0000.00% ROIICLRIcon10/2/2025Boost Price Target$192.31$190.00Equal Weight$0.0000.00% ROIGHGuardant Health10/2/2025Boost Price Target$62.65$70.00Overweight$0.0000.00% ROIFTREFortrea10/2/2025Boost Price Target$9.52$8.00Underweight$0.0000.00% ROIEXASExact Sciences10/2/2025Boost Price Target$56.43$65.00Overweight$0.0000.00% ROICERTCertara10/2/2025Boost Price Target$13.37$16.00Overweight$0.0000.00% ROIBRKRBruker10/2/2025Lower Price Target$34.72$40.00Overweight$0.0000.00% ROIAVTRAvantor10/2/2025Boost Price Target$13.69$15.00Overweight$0.0000.00% ROIAAgilent Technologies10/2/2025Boost Price Target$139.56$150.00Equal Weight$0.0000.00% ROIMTDMettler-Toledo International10/2/2025Boost Price Target$1,285.87$1,350.00Overweight$0.0000.00% ROICRLCharles River Laboratories International10/2/2025Upgrade$170.42$195.00Overweight$0.0000.00% ROITMOThermo Fisher Scientific9/11/2025Upgrade$477.03$550.00Overweight$0.0000.00% ROIAAgilent Technologies8/29/2025Reiterated Rating$124.70$125.00Equal Weight$0.0000.00% ROI7 Bankers Met in Secret (Now We Pay for It) (Ad)A little-known meeting in 1910 cost the average American family their entire financial freedom. They met in secret, used fake names, and told absolutely no one where they were going. On November 22nd, 1910, seven of America's most powerful bankers gathered on Jekyll Island to design the Federal Reserve. Their goal? To create a system where they control the money supply and you foot the bill. That system has created $38 trillion in debt, destroyed 98% of the dollar's purchasing power, and now they're preparing the final move: Central bank digital currencies (CBDCs). But if you have at least $100,000 saved and you're concerned about what's coming, you need to hear this.Watch now before this presentation is taken down.NTRANatera8/8/2025Reiterated Rating$141.08$210.00Overweight$0.0000.00% ROITXG10x Genomics8/8/2025Reiterated Rating$12.80$15.00Overweight$0.0000.00% ROIFTREFortrea8/7/2025Reiterated Rating$6.58$6.00Underweight$0.0000.00% ROIEXASExact Sciences8/7/2025Lower Price Target$46.91$55.00Overweight$0.0000.00% ROICRLCharles River Laboratories International8/7/2025Boost Price Target$150.60$165.00Equal Weight$0.0000.00% ROIAVTRAvantor8/4/2025Reiterated Rating$11.46$13.00Overweight$0.0000.00% ROIBRKRBruker8/4/2025Lower Price Target$34.72$43.00Overweight$0.0000.00% ROIINCYIncyte8/1/2025Initiated Coverage$74.89$90.00Overweight$0.0000.00% ROIILMNIllumina8/1/2025Boost Price Target$97.65$90.00Underweight$0.0000.00% ROIICLRIcon7/25/2025Boost Price Target$186.16$180.00Equal Weight$000.0000.00% ROITMOThermo Fisher Scientific7/24/2025Boost Price Target$466.84$490.00Equal Weight$000.0000.00% ROIMEDPMedpace7/23/2025Boost Price Target$477.73$450.00Equal Weight$000.0000.00% ROIIQVIQVIA7/23/2025Boost Price Target$187.89$185.00Equal Weight$000.0000.00% ROIPACBPacific Biosciences of California6/25/2025Lower Price Target$1.18$1.50Equal Weight$0.0000.00% ROIMEDPMedpace6/24/2025Initiated Coverage$308.64$300.00Equal Weight$000.0000.00% ROIMTDMettler-Toledo International6/24/2025Initiated Coverage$1,164.53$1,325.00Overweight$0000.0000.00% ROIQGENQiagen6/24/2025Initiated Coverage$49.18$57.89Overweight$00.0000.00% ROIRGENRepligen6/24/2025Initiated Coverage$120.11$150.00Overweight$000.0000.00% ROIWSTWest Pharmaceutical Services6/24/2025Initiated Coverage$217.05$245.00Equal Weight$000.0000.00% ROITXG10x Genomics6/24/2025Reiterated Rating$10.94$13.00Overweight$00.0000.00% ROITMOThermo Fisher Scientific6/24/2025Lower Price Target$401.19$450.00Equal Weight$000.0000.00% ROISHCSotera Health6/24/2025Lower Price Target$11.20$13.00Overweight$00.0000.00% ROICERTCertara5/8/2025Upgrade$11.46$14.00Overweight$0.0000.00% ROICRLCharles River Laboratories International5/8/2025Boost Price Target$141.77$155.00Equal Weight$000.0000.00% ROIBRKRBruker5/8/2025Lower Price Target$42.13$46.00Overweight$00.0000.00% ROIAVTRAvantor4/28/2025Lower Price Target$12.93$15.00Overweight$0.0000.00% ROIIQVIQVIA4/10/2025Reiterated Rating$157.02$170.00Equal Weight$000.0000.00% ROIICLRIcon4/10/2025Reiterated Rating$155.49$165.00Equal Weight$000.0000.00% ROIFTREFortrea4/10/2025Reiterated Rating$6.45$6.00Underweight$0.0000.00% ROIDHRDanaher4/10/2025Upgrade$192.18$205.00Overweight$000.0000.00% ROICRLCharles River Laboratories International4/10/2025Lower Price Target$128.77$145.00Equal Weight$000.0000.00% ROICERTCertara4/10/2025Lower Price Target$9.02$11.00Equal Weight$0.0000.00% ROIAVTRAvantor4/10/2025Lower Price Target$14.97$18.00Overweight$0.0000.00% ROITXG10x Genomics4/10/2025Lower Price Target$7.81$12.00Overweight$00.0000.00% ROITWSTTwist Bioscience4/10/2025Lower Price Target$35.90$45.00Overweight$00.0000.00% ROITMOThermo Fisher Scientific4/10/2025Lower Price Target$424.64$475.00Equal Weight$000.0000.00% ROISHCSotera Health4/10/2025Lower Price Target$10.61$12.00Overweight$00.0000.00% ROIFTREFortrea3/4/2025Lower Price Target$10.38$12.00Equal Weight$00.0000.00% ROICERTCertara2/28/2025Boost Price Target$11.87$13.00Equal Weight$0.0000.00% ROISHCSotera Health2/28/2025Lower Price Target$12.47$16.00Overweight$00.0000.00% ROIICLRIcon2/21/2025Lower Price Target$201.84$240.00Overweight$00.0000.00% ROISHCSotera Health2/18/2025Lower Price Target$13.48$17.00Overweight$00.0000.00% ROICRLCharles River Laboratories International2/18/2025Lower Price Target$152.07$166.00Equal Weight$000.0000.00% ROIAAgilent Technologies2/10/2025Upgrade$145.21$145.00Equal Weight$000.0000.00% ROIWATWaters2/10/2025Upgrade$408.96$415.00Equal Weight$000.0000.00% ROIAVTRAvantor2/10/2025Lower Price Target$19.15$23.00Overweight$00.0000.00% ROITXG10x Genomics2/10/2025Lower Price Target$14.25$18.00Overweight$00.0000.00% ROITWSTTwist Bioscience2/3/2025Set Price Target$41.31$58.00Overweight$00.0000.00% ROIAVTRAvantor2/3/2025Boost Price Target$22.15$26.00Overweight$00.0000.00% ROIIQVIQVIA2/3/2025Lower Price Target$200.31$235.00Overweight$000.0000.00% ROI[URGENT] Mode Mobile terms changing Aug 14 (Ad)Mode Mobile has secured its Nasdaq ticker, $MODE, while still in the pre-IPO stage. More than 60,000 investors have already put over $100 million into the company, including original Shark Tank investor Kevin Harrington. The company reports 490M+ users, $115M+ in lifetime revenue, and $1B+ earned and saved by users across 170+ countries. Deloitte ranked Mode North America's #1 fastest-growing software company in 2023 after 32,481% growth. Pre-IPO shares are currently priced at 0.52 dollars, but that price is set to change on August 14.See full pre-IPO share details before the August 14 deadlineDHRDanaher1/30/2025Lower Price Target$223.12$240.00Equal Weight$000.0000.00% ROIEXASExact Sciences1/23/2025Initiated Coverage$54.79$70.00Overweight$000.0000.00% ROIGHGuardant Health1/23/2025Initiated Coverage$47.20$60.00Overweight$000.0000.00% ROINTRANatera1/23/2025Initiated Coverage$171.93$200.00Overweight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupThe Goldman Sachs GroupWeiss RatingsCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.